https://www.biospace.com/article/releases/yumanity-therapeutics-initiates-phase-1-clinical-trial-of-lead-candidate-ytx-7739-for-the-treatment-of-parkinson-s-disease/
Yumanity Therapeutics Initiates Phase 1 Clinical Trial of Lead Candidate YTX-7739 for the Treatment of Parkinson’s Disease